Bispecific Antibodies Deliver One-Two Punch to Non-Hodgkin Lymphoma

Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated May 15th, 2024

Bispecific Antibodies Deliver One-Two Punch to Non-Hodgkin Lymphoma

NOW
PLAYING
Actor Ken Jeong’s Love For Wife, as a Mom and Breast Cancer Survivor
NOW
PLAYING
At 74, Jeff Bridges, Is Set to Revive 'Tron', The Best Movie Ever Made About Video Games- His Remarkable Saga Since The 80s
NOW
PLAYING
Rising Above Petty Drama, Housewives Stars Guerdy Abraira, 46, Says There’s No ‘Bad Blood’ With Larsa Pippen, 49, After She Revealed Cancer Diagnosis Without Permission
NOW
PLAYING
‘Seinfeld’ Actress & Cancer Survivor Julia Louis-Dreyfus on ‘Downside’ of Fame
NOW
PLAYING
Groundbreaking CAR T-Cell Therapy Approved For Earlier Use in Relapsed Myeloma Patients
NOW
PLAYING
The Drug Ribociclib Plus Endocrine Therapy Extends Life, Slows Spread in Early Breast Cancer

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... non-hodgkin lymphoma trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.